Starting later this year, Ouro intends to start a phase 1 clinical trial of its own, eyeing the development of the drug for ...
Portfolio Receipts expected to be approximately $2,800 million, at the upper end of guidance range <li /> <stro ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback